Viroblock

About:

Viroblock is a Swiss company focused on developing a novel anti-viral technology suited for air filtration products.

Twitter/X: Viroblock

Top Investors: StartAngels Network, BlueOcean Ventures, Fongit Seed Invest, Initiative Capital Romandie

Description:

Viroblock is a Swiss based company focused on developing a novel anti-viral technology that is both rapid acting and broad spectrum. Applied to non-woven fabric, the technology is particularly suited for air filtration products. In fact, previous work has shown Viroblock fabric to kill over 99% of H5N1 viruses when challenged in standardized aerobiology experiments.

Total Funding Amount:

4.1M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Geneva, Geneve, Switzerland

Founded Date:

2005-11-01

Contact Email:

info(AT)viroblock.com

Founders:

Donald Wallach

Number of Employees:

1-10

Last Funding Date:

2012-02-14

IPO Status:

Private

Industries: